Breast - Refresher 2022
Breast cancer is one of the most common malignancies treated by radiation oncologists. Indications for radiation in patients with breast cancer are increasingly dependent on advances in surgery and systemic treatments and improved understanding of tumor biology. Recent clinical trials indicate a variety of fractionation regimens involving whole breast or partial breast treatment are equally effective in patients with early stage breast cancer.
This course reviews the latest evidence supporting hypofractionated and ultrashort hypofractionated treatment regimens as well as indications for post mastectomy and regional nodal irradiation. Radiation techniques will also be discussed.
Lastly, novel systemic and targeted therapies are being rapidly approved in patients with breast cancer, and this course serves to increase awareness regarding potential interactions between radiation and these treatments.
This activity is available from May 23, 2022, through 11:59 p.m. Eastern time on May 22, 2025.
This activity was originally recorded at ASTRO’s virtual 2022 ASTRO Annual Refresher Course, March 27-27, 2022.
Target Audience
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents, medical oncologists, surgeons, physicists, nurses, radiation therapists and dosimetrists.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Discuss a variety of equally effective radiation treatment options for patients with early stage breast cancer and determine the best option for the individual patient through shared decision making.
- Determine when and how to perform regional nodal irradiation.
- Determine the best radiation technique for delivering treatment to an individual patient.
Mylin Torres, MD is employed by Emory University School of Medicine and receives compensation from Varian, Pfizer, OncoHelath, MJHLife Sciences, Genentech and BioAscend.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until May 22, 2025, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.